Clear Cell Adenocarcinoma of Uterine Cervix: A Single Institution Retrospective Experience

• Published in: Frontiers in oncology 2020-11, Vol.10, p.532748-532748
• Main Authors: Liu, Zhimin, Li, Junyun, Gu, Haifeng, Tu, Hua, Liu, Guochen, Liu, Jihong
• Format: Article
• Language: English
• Subjects: cervix; clear cell carcinoma; Oncology; prognosis; radiotherapy; surgery
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2020.532748

The purpose of the study is to summarize the clinical characteristics and identify the prognosis of clear cell adenocarcinoma of the uterine cervix (CCAUC) in patients without a history of diethylstilbestrol (DES) exposure. Forty-two patients with CCAUC, treated initially at Sun Yat-sen University Cancer Center between 1985 and 2017, were studied. Of all the CCAUC patients, the median age was 47 years old, and the median tumor size was 3 cm. Thirty-four early stage patients (IB = 28, IIA = 6) underwent radical surgery. Eight advanced stage patients (IIB = 8) received concurrent chemoradiotherapy (n = 4) or radical surgery (n = 4). Survival analysis showed that patients with early stage (IB-IIA) had a significantly better 5-year progression-free survival (PFS) and overall survival (OS) than those with advanced stage (IIB) (  0.05). The FIGO stage and pelvic node status were important prognostic factors for both PFS and OS. For treatment modality, we recommended that radical surgery alone was used in early stage patients without high risk factors. Ovarian preservation in early stage patients involved some risk.